Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Effect of hepatic impairment on single-dose pharmacokinetics of daclatasvir investigated

Nov. 15, 2011

New PAI-1 inhibitor ameliorates experimental collapsing focal segmental glomerulosclerosis

Nov. 15, 2011

Analgesia seen with NP-2 in phase I study

Nov. 14, 2011

Pharmacokinetics and safety of E-7050 assessed in humans

Nov. 14, 2011

PRT-201 shows promise in patients with kidney disease on hemodialysis

Nov. 14, 2011

Novel clinical data and analyses presented on Regeneron's rilonacept

Nov. 14, 2011

Tocilizumab assessed in large vessel vasculitis

Nov. 14, 2011

LB-80380 compared to entecavir in phase IIb trial

Nov. 14, 2011

Hepatitis C virus resistance characterized in multiple-dose trial of GS-5885

Nov. 14, 2011

First-in-human data released on candidate hepatitis C therapy

Nov. 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...